Literature DB >> 24793871

[Indicators for drug selection in health systems: an integrative review].

Rafael Santos Santana1, Elisdete Maria Santos de Jesus2, Diana Graziele dos Santos2, Divaldo Pereira de Lyra Júnior2, Silvana Nair Leite3, Wellington Barros da Silva2.   

Abstract

OBJECTIVE: To produce a panel of the main drug selection indicators by performing an integrative literature review.
METHODS: After the elaboration of a review protocol, searches were conducted in LILACS, MEDLINE, Embase, and SciELO databases. The following search terms were used: "indicators"; "criteria"; "drug selection"; "pharmacy and therapeutics committee"; and "medication form"; with the applicable variations in English and Spanish. Sixteen original articles published between January 1996 and March 2012 were retrieved and reviewed to compose a panel of indicators.
RESULTS: Forty-five quantitative and qualitative indicators were identified. These indicators were grouped according to conceptual similarities in three categories: 1) assessment of pharmacy and therapeutics committee structure; 2) evaluation of the general processes of drug selection; and 3) evaluation of the results of drug selection.
CONCLUSIONS: The indicators identified reveal relative uniformity in the established patterns for drug selection. The group of indicators established in this study should serve as reference for the development and consolidation of drug selection in public health services.

Mesh:

Year:  2014        PMID: 24793871

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  1 in total

1.  Characterization of the selection of medicines for the Brazilian primary health care.

Authors:  Margô Gomes de Oliveira Karnikowski; Dayani Galato; Micheline Marie Milward de Azevedo Meiners; Emília Vitória da Silva; Letícia Farias Gerlack; Ângelo José Gonçalves Bós; Silvana Nair Leite; Juliana Álvares; Ione Aquemi Guibu; Orlando Mario Soeiro; Karen Sarmento Costa; Ediná Alves Costa; Augusto Afonso Guerra; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.